Tapewire

OTC · USD

PURE

PURE BIOSCIENCE, INC.

Export transactions ↓
Tapewire entity
7969
SEC CIK
0001006028
Parsed reports
110

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 28, 2018 Filed Jul 2, 2018 23:26 UTC
Chen IvanDirector
GrantStock Option (Right to Buy) · Derivative 200,000 $0.00 Strike: $0.65 $0.00
Disclosure

SEC source: 0001209191-18-040506 · doc4.xml · derivative · entry 2

Chen Ivan · CIK 0001743729 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2028-06-28

F2 · derivative.exercise_date: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020.

Read SEC document
June 28, 2018 Filed Jul 2, 2018 23:26 UTC
Chen IvanDirector
GrantCommon Stock 150,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-040506 · doc4.xml · nonDerivative · entry 1

Chen Ivan · CIK 0001743729 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). The RSUs vest and become exercisable as follows: (i) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020.

Read SEC document
February 26, 2018 Filed Mar 1, 2018 00:19 UTC
Pfanzelter David JDirector · Chairman of the Board
GrantStock Options (Right to Buy) · Derivative 200,000 $0.00 Strike: $0.78 $0.00
Disclosure

SEC source: 0001209191-18-014705 · doc4.xml · derivative · entry 1

Pfanzelter David J · CIK 0001569467 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2023-02-26

F1 · derivative.exercise_date: 25% of the option shares shall vest and become exercisable in four equal quarterly installments beginning on May 26, 2018.

Read SEC document
February 26, 2018 Filed Mar 1, 2018 00:18 UTC
Otis WilliamDirector
GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $0.78 $0.00
Disclosure

SEC source: 0001209191-18-014700 · doc4.xml · derivative · entry 1

Otis William · CIK 0001589472 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2023-02-27

F1 · derivative.exercise_date: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020.

Read SEC document
February 26, 2018 Filed Mar 1, 2018 00:17 UTC
Lee Tom YDirector
GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $0.78 $0.00
Disclosure

SEC source: 0001209191-18-014698 · doc4.xml · derivative · entry 1

Lee Tom Y · CIK 0001623609 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2023-02-27

F1 · derivative.exercise_date: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020.

Read SEC document
February 26, 2018 Filed Mar 1, 2018 00:16 UTC
Lambert Henry R.Director · Chief Executive Officer
GrantStock Options (Right to Buy) · Derivative 200,000 $0.00 Strike: $0.78 $0.00
Disclosure

SEC source: 0001209191-18-014696 · doc4.xml · derivative · entry 1

Lambert Henry R. · CIK 0001587257 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2023-02-26

F1 · derivative.exercise_date: 25% of the option shares shall vest and become exercisable in four equal quarterly installments beginning on May 26, 2018.

Read SEC document
February 26, 2018 Filed Mar 1, 2018 00:15 UTC GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $0.78 $0.00
Disclosure

SEC source: 0001209191-18-014693 · doc4.xml · derivative · entry 1

Hagen Elisabeth · CIK 0001721211 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2023-02-27

F1 · derivative.exercise_date: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020.

Read SEC document
February 26, 2018 Filed Mar 1, 2018 00:14 UTC GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $0.78 $0.00
Disclosure

SEC source: 0001209191-18-014692 · doc4.xml · derivative · entry 1

Field Janet Risi · CIK 0001713140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2023-02-27

F1 · derivative.exercise_date: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020.

Read SEC document
February 26, 2018 Filed Mar 1, 2018 00:13 UTC
Elliott Mark StuartVice President, Finance
GrantStock Options (Right to Buy) · Derivative 150,000 $0.00 Strike: $1.15 $0.00
Disclosure

SEC source: 0001209191-18-014690 · doc4.xml · derivative · entry 3

Elliott Mark Stuart · CIK 0001649406 · Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2021-05-11

F2 · kind: The two reported transactions involve an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on May 11, 2016 with an exercise period of 2 years. The term of the option has been amended to extend the exercise period to five years from the date of grant.

F3 · derivative.exercise_date: 25% of the option shares shall vest and become exercisable in four equal quarterly installments beginning on August 11, 2016.

Read SEC document
February 26, 2018 Filed Mar 1, 2018 00:13 UTC
Elliott Mark StuartVice President, Finance
Disposition to issuerStock Options (Right to Buy) · Derivative 150,000 $0.00 Strike: $1.15 $0.00
Disclosure

SEC source: 0001209191-18-014690 · doc4.xml · derivative · entry 2

Elliott Mark Stuart · CIK 0001649406 · Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 150,000 shares

Expires 2018-05-11

F2 · kind: The two reported transactions involve an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on May 11, 2016 with an exercise period of 2 years. The term of the option has been amended to extend the exercise period to five years from the date of grant.

F3 · derivative.exercise_date: 25% of the option shares shall vest and become exercisable in four equal quarterly installments beginning on August 11, 2016.

Read SEC document
February 26, 2018 Filed Mar 1, 2018 00:13 UTC
Elliott Mark StuartVice President, Finance
GrantStock Options (Right to Buy) · Derivative 150,000 $0.00 Strike: $0.78 $0.00
Disclosure

SEC source: 0001209191-18-014690 · doc4.xml · derivative · entry 1

Elliott Mark Stuart · CIK 0001649406 · Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2023-02-26

F1 · derivative.exercise_date: 25% of the option shares shall vest and become exercisable in four equal quarterly installments beginning on May 26, 2018.

Read SEC document
February 26, 2018 Filed Mar 1, 2018 00:10 UTC
Cohee GaryDirector
GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $0.78 $0.00
Disclosure

SEC source: 0001209191-18-014687 · doc4.xml · derivative · entry 1

Cohee Gary · CIK 0001453116 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2023-02-27

F1 · derivative.exercise_date: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020.

Read SEC document
January 12, 2018 Filed Jan 12, 2018 22:38 UTC
Lambert Henry R.Director · Chief Executive Officer
SaleCommon Stock 11,323 $0.90 $10,190.70
Disclosure

SEC source: 0001209191-18-003458 · doc4.xml · nonDerivative · entry 5

Lambert Henry R. · CIK 0001587257 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 498,056

Read SEC document
January 12, 2018 Filed Jan 12, 2018 22:38 UTC
Lambert Henry R.Director · Chief Executive Officer
SaleCommon Stock 9,000 $0.94 $8,460.00
Disclosure

SEC source: 0001209191-18-003458 · doc4.xml · nonDerivative · entry 4

Lambert Henry R. · CIK 0001587257 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 509,379

Read SEC document
January 12, 2018 Filed Jan 12, 2018 22:38 UTC
Lambert Henry R.Director · Chief Executive Officer
SaleCommon Stock 677 $0.93 $629.61
Disclosure

SEC source: 0001209191-18-003458 · doc4.xml · nonDerivative · entry 3

Lambert Henry R. · CIK 0001587257 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 518,379

Read SEC document
January 11, 2018 Filed Jan 12, 2018 22:38 UTC
Lambert Henry R.Director · Chief Executive Officer
SaleCommon Stock 2,000 $0.94 $1,880.00
Disclosure

SEC source: 0001209191-18-003458 · doc4.xml · nonDerivative · entry 2

Lambert Henry R. · CIK 0001587257 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 519,056

Read SEC document
January 10, 2018 Filed Jan 12, 2018 22:38 UTC
Lambert Henry R.Director · Chief Executive Officer
SaleCommon Stock 18,500 $0.94 $17,390.00
Disclosure

SEC source: 0001209191-18-003458 · doc4.xml · nonDerivative · entry 1

Lambert Henry R. · CIK 0001587257 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 521,056

Read SEC document
December 29, 2017 Filed Dec 29, 2017 22:12 UTC
Lee Tom YDirector
PurchaseWarrant · Derivative 2,133,333 Not disclosed Strike: $0.75 Not disclosed
Disclosure

SEC source: 0001209191-17-067662 · doc4.xml · derivative · entry 4

Lee Tom Y · CIK 0001623609 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Plum Investments, L.P.

Disclosed balance after: 2,133,333

Underlying: Common Stock · 2,133,333 shares

Expires 2019-08-29

F1 · kind: Represents a private purchase under the terms of a Securities Transfer Agreement between Reporting Person and Franchise Brands, LLC for an aggregate purchase price of $8,399,999.70.

F1 · price: Represents a private purchase under the terms of a Securities Transfer Agreement between Reporting Person and Franchise Brands, LLC for an aggregate purchase price of $8,399,999.70.

F2 · ownership.nature: Mr. Lee is the general partner and sole limited partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P.

Read SEC document
December 29, 2017 Filed Dec 29, 2017 22:12 UTC
Lee Tom YDirector
PurchaseCommon Stock 18,666,666 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-17-067662 · doc4.xml · nonDerivative · entry 1

Lee Tom Y · CIK 0001623609 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Plum Investments, L.P.

Disclosed balance after: 18,666,666

F1 · kind: Represents a private purchase under the terms of a Securities Transfer Agreement between Reporting Person and Franchise Brands, LLC for an aggregate purchase price of $8,399,999.70.

F1 · price: Represents a private purchase under the terms of a Securities Transfer Agreement between Reporting Person and Franchise Brands, LLC for an aggregate purchase price of $8,399,999.70.

F2 · ownership.nature: Mr. Lee is the general partner and sole limited partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P.

Read SEC document
December 29, 2017 Filed Dec 29, 2017 22:11 UTC SaleWarrant · Derivative 2,133,333 Not disclosed Strike: $0.75 Not disclosed
Disclosure

SEC source: 0001209191-17-067658 · doc4.xml · derivative · entry 2

Franchise Brands, LLC · CIK 0001618371 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,133,333 shares

Expires 2019-08-22

F1 · kind: Represents a private sale under the terms of a Securities Transfer Agreement between Reporting Person and Plum Investments, L.P. for an aggregate purchase price of $8,399,999.70.

F1 · price: Represents a private sale under the terms of a Securities Transfer Agreement between Reporting Person and Plum Investments, L.P. for an aggregate purchase price of $8,399,999.70.

Read SEC document
December 29, 2017 Filed Dec 29, 2017 22:11 UTC SaleCommon Stock 18,666,666 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-17-067658 · doc4.xml · nonDerivative · entry 1

Franchise Brands, LLC · CIK 0001618371 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Represents a private sale under the terms of a Securities Transfer Agreement between Reporting Person and Plum Investments, L.P. for an aggregate purchase price of $8,399,999.70.

F1 · price: Represents a private sale under the terms of a Securities Transfer Agreement between Reporting Person and Plum Investments, L.P. for an aggregate purchase price of $8,399,999.70.

Read SEC document
November 02, 2017 Filed Nov 3, 2017 21:12 UTC GrantStock Option (Right to Buy) · Derivative 200,000 $0.00 Strike: $1.11 $0.00
Disclosure

SEC source: 0001209191-17-059249 · doc4.xml · derivative · entry 2

Hagen Elisabeth · CIK 0001721211 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2027-11-02

F2 · derivative.exercise_date: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019.

Read SEC document
November 02, 2017 Filed Nov 3, 2017 21:12 UTC GrantCommon Stock 150,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-059249 · doc4.xml · nonDerivative · entry 1

Hagen Elisabeth · CIK 0001721211 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). The RSUs vest and become exercisable as follows: (i) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019.

Read SEC document
September 25, 2017 Filed Sep 27, 2017 22:17 UTC
Pfanzelter David JDirector · Chairman of the Board
Exercise / conversionWarrant · Derivative 16,000 Not disclosed Strike: $0.60 Not disclosed
Disclosure

SEC source: 0001209191-17-054171 · doc4.xml · derivative · entry 4

Pfanzelter David J · CIK 0001569467 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,000 shares

Expires 2017-09-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised his 2014 Warrant in full and in cash on September 25, 2017.

F2 · price: In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised his 2014 Warrant in full and in cash on September 25, 2017.

Read SEC document
September 25, 2017 Filed Sep 27, 2017 22:17 UTC
Pfanzelter David JDirector · Chairman of the Board
GrantWarrant · Derivative 16,000 Not disclosed Strike: $0.60 Not disclosed
Disclosure

SEC source: 0001209191-17-054171 · doc4.xml · derivative · entry 3

Pfanzelter David J · CIK 0001569467 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 16,000 shares

Expires 2017-09-25

F1 · kind: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended.

F1 · price: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended.

Read SEC document
September 25, 2017 Filed Sep 27, 2017 22:17 UTC
Pfanzelter David JDirector · Chairman of the Board
Disposition to issuerWarrant · Derivative 16,000 Not disclosed Strike: $0.75 Not disclosed
Disclosure

SEC source: 0001209191-17-054171 · doc4.xml · derivative · entry 2

Pfanzelter David J · CIK 0001569467 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,000 shares

Expires 2019-07-02

F1 · kind: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended.

F1 · price: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended.

Read SEC document
September 25, 2017 Filed Sep 27, 2017 22:17 UTC
Pfanzelter David JDirector · Chairman of the Board
Exercise / conversionCommon Stock 16,000 $0.60 $9,600.00
Disclosure

SEC source: 0001209191-17-054171 · doc4.xml · nonDerivative · entry 1

Pfanzelter David J · CIK 0001569467 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 556,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 25, 2017 Filed Sep 27, 2017 22:14 UTC
Otis WilliamDirector
Exercise / conversionWarrant · Derivative 9,066 Not disclosed Strike: $0.60 Not disclosed
Disclosure

SEC source: 0001209191-17-054170 · doc4.xml · derivative · entry 4

Otis William · CIK 0001589472 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,066 shares

Expires 2017-09-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised his 2014 Warrant in full and in cash on September 25, 2017.

F2 · price: In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised his 2014 Warrant in full and in cash on September 25, 2017.

Read SEC document
September 25, 2017 Filed Sep 27, 2017 22:14 UTC
Otis WilliamDirector
GrantWarrant · Derivative 9,066 Not disclosed Strike: $0.60 Not disclosed
Disclosure

SEC source: 0001209191-17-054170 · doc4.xml · derivative · entry 3

Otis William · CIK 0001589472 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,066

Underlying: Common Stock · 9,066 shares

Expires 2017-09-25

F1 · kind: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended.

F1 · price: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended.

Read SEC document
September 25, 2017 Filed Sep 27, 2017 22:14 UTC
Otis WilliamDirector
Disposition to issuerWarrant · Derivative 9,066 Not disclosed Strike: $0.75 Not disclosed
Disclosure

SEC source: 0001209191-17-054170 · doc4.xml · derivative · entry 2

Otis William · CIK 0001589472 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,066 shares

Expires 2019-08-01

F1 · kind: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended.

F1 · price: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended.

Read SEC document
September 25, 2017 Filed Sep 27, 2017 22:14 UTC
Otis WilliamDirector
Exercise / conversionCommon Stock 9,066 $0.60 $5,439.60
Disclosure

SEC source: 0001209191-17-054170 · doc4.xml · nonDerivative · entry 1

Otis William · CIK 0001589472 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 181,732

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 25, 2017 Filed Sep 27, 2017 22:13 UTC
Lee Tom YDirector
Exercise / conversionWarrant · Derivative 166,666 Not disclosed Strike: $0.40 Not disclosed
Disclosure

SEC source: 0001209191-17-054169 · doc4.xml · derivative · entry 8

Lee Tom Y · CIK 0001623609 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Wife

Disclosed balance after: 0

Underlying: Common Stock · 166,666 shares

Expires 2017-09-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · kind: In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised her 2015 Warrant in full and in cash on September 25, 2017.

F4 · price: In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised her 2015 Warrant in full and in cash on September 25, 2017.

Read SEC document
September 25, 2017 Filed Sep 27, 2017 22:13 UTC
Lee Tom YDirector
GrantWarrant · Derivative 166,666 Not disclosed Strike: $0.40 Not disclosed
Disclosure

SEC source: 0001209191-17-054169 · doc4.xml · derivative · entry 7

Lee Tom Y · CIK 0001623609 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Wife

Disclosed balance after: 166,666

Underlying: Common Stock · 166,666 shares

Expires 2017-09-25

F3 · kind: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2015 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2015 Warrant held by the Reporting Person were amended.

F3 · price: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2015 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2015 Warrant held by the Reporting Person were amended.

Read SEC document
September 25, 2017 Filed Sep 27, 2017 22:13 UTC
Lee Tom YDirector
Disposition to issuerWarrant · Derivative 166,666 Not disclosed Strike: $0.45 Not disclosed
Disclosure

SEC source: 0001209191-17-054169 · doc4.xml · derivative · entry 6

Lee Tom Y · CIK 0001623609 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Wife

Disclosed balance after: 0

Underlying: Common Stock · 166,666 shares

Expires 2020-11-23

F3 · kind: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2015 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2015 Warrant held by the Reporting Person were amended.

F3 · price: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2015 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2015 Warrant held by the Reporting Person were amended.

Read SEC document
September 25, 2017 Filed Sep 27, 2017 22:13 UTC
Lee Tom YDirector
Exercise / conversionWarrant · Derivative 320,000 Not disclosed Strike: $0.60 Not disclosed
Disclosure

SEC source: 0001209191-17-054169 · doc4.xml · derivative · entry 5

Lee Tom Y · CIK 0001623609 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 320,000 shares

Expires 2017-09-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised his 2014 Warrant in full and in cash on September 25, 2017.

F2 · price: In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised his 2014 Warrant in full and in cash on September 25, 2017.

Read SEC document
September 25, 2017 Filed Sep 27, 2017 22:13 UTC
Lee Tom YDirector
GrantWarrant · Derivative 320,000 Not disclosed Strike: $0.60 Not disclosed
Disclosure

SEC source: 0001209191-17-054169 · doc4.xml · derivative · entry 4

Lee Tom Y · CIK 0001623609 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 320,000

Underlying: Common Stock · 320,000 shares

Expires 2017-09-25

F1 · kind: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended.

F1 · price: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended.

Read SEC document
September 25, 2017 Filed Sep 27, 2017 22:13 UTC
Lee Tom YDirector
Disposition to issuerWarrant · Derivative 320,000 Not disclosed Strike: $0.75 Not disclosed
Disclosure

SEC source: 0001209191-17-054169 · doc4.xml · derivative · entry 3

Lee Tom Y · CIK 0001623609 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 320,000 shares

Expires 2019-08-29

F1 · kind: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended.

F1 · price: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended.

Read SEC document
September 25, 2017 Filed Sep 27, 2017 22:13 UTC
Lee Tom YDirector
Exercise / conversionCommon Stock 166,666 $0.40 $66,666.40
Disclosure

SEC source: 0001209191-17-054169 · doc4.xml · nonDerivative · entry 2

Lee Tom Y · CIK 0001623609 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Wife

Disclosed balance after: 717,665

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 25, 2017 Filed Sep 27, 2017 22:13 UTC
Lee Tom YDirector
Exercise / conversionCommon Stock 320,000 $0.60 $192,000.00
Disclosure

SEC source: 0001209191-17-054169 · doc4.xml · nonDerivative · entry 1

Lee Tom Y · CIK 0001623609 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,154,452

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 25, 2017 Filed Oct 10, 2017 21:52 UTC Amendment
Lee Tom YDirector
Exercise / conversionWarrant · Derivative 208,038 Not disclosed Strike: $0.40 Not disclosed
Disclosure

SEC source: 0001209191-17-056515 · doc4a.xml · derivative · entry 4

Lee Tom Y · CIK 0001623609 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 208,038 shares

Expires 2017-09-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The original Form 4 Report filed on September 27, 2017 inadvertently omitted the amendment and exercise of an additional warrant.

F3 · kind: In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised his 2015 Warrant in full and in cash on September 25, 2017.

F3 · price: In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised his 2015 Warrant in full and in cash on September 25, 2017.

Read SEC document
September 25, 2017 Filed Oct 10, 2017 21:52 UTC Amendment
Lee Tom YDirector
GrantWarrant · Derivative 208,038 Not disclosed Strike: $0.40 Not disclosed
Disclosure

SEC source: 0001209191-17-056515 · doc4a.xml · derivative · entry 3

Lee Tom Y · CIK 0001623609 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 208,038

Underlying: Common Stock · 208,038 shares

Expires 2017-09-25

F1 · security: The original Form 4 Report filed on September 27, 2017 inadvertently omitted the amendment and exercise of an additional warrant.

F2 · kind: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2015 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2015 Warrant held by the Reporting Person were amended.

F2 · price: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2015 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2015 Warrant held by the Reporting Person were amended.

Read SEC document
September 25, 2017 Filed Oct 10, 2017 21:52 UTC Amendment
Lee Tom YDirector
Disposition to issuerWarrant · Derivative 208,038 Not disclosed Strike: $0.45 Not disclosed
Disclosure

SEC source: 0001209191-17-056515 · doc4a.xml · derivative · entry 2

Lee Tom Y · CIK 0001623609 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 208,038 shares

Expires 2020-11-23

F1 · security: The original Form 4 Report filed on September 27, 2017 inadvertently omitted the amendment and exercise of an additional warrant.

F2 · kind: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2015 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2015 Warrant held by the Reporting Person were amended.

F2 · price: On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2015 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2015 Warrant held by the Reporting Person were amended.

Read SEC document
September 25, 2017 Filed Oct 10, 2017 21:52 UTC Amendment
Lee Tom YDirector
Exercise / conversionCommon Stock 208,038 $0.40 $83,215.20
Disclosure

SEC source: 0001209191-17-056515 · doc4a.xml · nonDerivative · entry 1

Lee Tom Y · CIK 0001623609 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,362,490

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The original Form 4 Report filed on September 27, 2017 inadvertently omitted the amendment and exercise of an additional warrant.

Read SEC document
August 23, 2017 Filed Aug 24, 2017 23:19 UTC GrantStock Option (Right to Buy) · Derivative 200,000 $0.00 Strike: $1.21 $0.00
Disclosure

SEC source: 0001209191-17-050214 · doc4.xml · derivative · entry 2

Field Janet Risi · CIK 0001713140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2027-08-23

F2 · derivative.exercise_date: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019.

Read SEC document
August 23, 2017 Filed Aug 24, 2017 23:19 UTC GrantCommon Stock 150,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-050214 · doc4.xml · nonDerivative · entry 1

Field Janet Risi · CIK 0001713140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,140

F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). The RSUs vest and become exercisable as follows: (i) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019.

Read SEC document
June 22, 2017 Filed Jun 26, 2017 20:59 UTC
Pfanzelter David JDirector · Chairman of the Board
GrantStock Options (Right to Buy) · Derivative 1,000,000 $0.00 Strike: $1.19 $0.00
Disclosure

SEC source: 0001209191-17-041856 · doc4.xml · derivative · entry 2

Pfanzelter David J · CIK 0001569467 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common Stock · 1,000,000 shares

Expires 2027-06-22

F3 · derivative.exercise_date: 25% of the option shares shall vest and become exercisable on December 31, 2018 with the remaining shares vesting in 3 equal annual installments thereafter.

Read SEC document
June 22, 2017 Filed Jun 26, 2017 20:59 UTC
Pfanzelter David JDirector · Chairman of the Board
GrantCommon Stock 500,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-041856 · doc4.xml · nonDerivative · entry 1

Pfanzelter David J · CIK 0001569467 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 540,000

F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest on December 31, 2018 with the remaining shares vesting in 3 equal annual installments thereafter. Vested shares will be delivered to the Reporting Person on the earlier of (i) the ten-year anniversary of the Grant Date; (ii) sixty days after the date the Grantee's Service ceases for any reason and such cessation constitutes a "separation from service" within the meaning of Section 409A of the Code; (iii) the date of Grantee's death or (iv) the date of a Change in Control that constitutes a "change in control event" within the meaning of Section 409A of the Code.

F2 · balance_after: Reflects the cancellation of 2,800,000 Restricted Stock Units pursuant to an RSU Cancellation Agreement, dated December 13, 2016.

Read SEC document
June 22, 2017 Filed Jun 26, 2017 20:57 UTC
Otis WilliamDirector
GrantStock Option (Right to Buy) · Derivative 200,000 $0.00 Strike: $1.19 $0.00
Disclosure

SEC source: 0001209191-17-041854 · doc4.xml · derivative · entry 2

Otis William · CIK 0001589472 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2027-06-22

F3 · derivative.exercise_date: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019.

Read SEC document
June 22, 2017 Filed Jun 26, 2017 20:57 UTC
Otis WilliamDirector
GrantCommon Stock 150,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-041854 · doc4.xml · nonDerivative · entry 1

Otis William · CIK 0001589472 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,666

F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). The RSUs vest as follows: (i) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019. Vested shares will be delivered to the Reporting Person on the earlier of (i) the ten-year anniversary of the Grant Date; (ii) sixty days after the date the Grantee's Service ceases for any reason and such cessation constitutes a "separation from service" within the meaning of Section 409A of the Code; (iii) the date of Grantee's death or (iv) the date of a Change in Control that constitutes a "change in control event" within the meaning of Section 409A of the Code.

F2 · balance_after: Reflects the cancellation of 200,000 Restricted Stock Units pursuant to the RSU Cancellation Agreement between the Issuer and the Reporting Person, dated December 13, 2016.

Read SEC document
June 22, 2017 Filed Jun 26, 2017 20:55 UTC
Lee Tom YDirector
GrantStock Option (Right to Buy) · Derivative 200,000 $0.00 Strike: $1.19 $0.00
Disclosure

SEC source: 0001209191-17-041852 · doc4.xml · derivative · entry 2

Lee Tom Y · CIK 0001623609 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2027-06-22

F2 · derivative.exercise_date: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.